Documente Academic
Documente Profesional
Documente Cultură
*Corresponding Author
Corresponding Address:
Dr. Khalifa Sifaw Ghenghesh,
Associate Professor,
P.O. Box 80013,
Tripoli - Libya
Fax: +218 21 360 29 71
e-mail: ghenghesh_micro@yahoo.com
2. Microbiology:
In addition to Shigella spp., Aeromonas, Campylobacter, Salmonella, and Yersinia
enterocolitica were also identified using standard techniques.5 Campylobacter was looked for in
95 cases and 95 controls.
To isolate shigellae, stool samples were plated onto MacConkey and Salmonella-Shigella
agars and incubated at 37oC for 24-48 hours. Non-lactose fermenting colonies were identified
using API 20E. Isolates identified as Shigella spp. were serogrouped and serotyped using
commercially available antisera (Wellcome Diagnostics, UK). Stools were also examined for the
presence of frank blood and mucus.
The disc diffusion method6 was used to determine the sensitivity of the isolates to the
following antibiotics (Oxoid, UK): ampicillin, chloramphenicol, ceftriaxone, ciprofloxacin,
gentamicin, kanamycin, nalidixic acid, norfloxacin, streptomycin and trimethoprim-
sulphamethoxazole.
RESULTS:
Shigella spp. were isolated from 9(5.7%) cases and from 2(1.3%) controls (odds ratio,
4.7; P = 0.03). Of the children with diarrhoea, shigellae were isolated equally from both sexes (5
from 85 males and 4 from 72 females). A total of 6 Sh. flexneri (all from patients) and 5 Sh.
sonnei (3 from patients) were isolated. Of the 6 strains of Sh. flexneri, 4 were of Sh. flexneri type
2, 1 of Sh. flexneri type 1 and 1 of Sh. flexneri type 3. Of the 9 Shigella strains from cases,
5(56%) were isolated in autumn, 1(11%) in winter, 1(11%) in spring and 2(22%) in summer.
Both isolates from controls were detected in autumn. Other enteropathogens include, Aeromonas
spp. from 15% of cases and 18% of controls, Campylobacter spp. from 6% and 3%, Salmonella
spp. from 11% and 4%, and Yersinia enterocolitica from 0.06% and 0.0% respectively.
Three Shigella strains were isolated from 50 children with diarrhoea aged 6 months to
one year, 6 strains from 24 cases aged more than one year old and none were isolated from
children less than 6 months old. All patients (100%) were on artificial feeding, 7 (78%) used
untreated drinking water, 1 took Bactrim 2 days prior to stool collection and none travelled
abroad in the last 30 days from stool collection. Blood and mucus were seen in the stool of 5
(56%) patients with diarrhoea. Clinical examination showed 6(67%) with fever and 3(33%) with
vomiting, 1 (11%) diagnosed as septicaemic and 1 (11%) as having generalized convulsions.
Clinical findings are shown in Table.
Of the 11 Shigella strains, 36% were resistant to ampicillin, 27% to chloramphenicol, 9%
to kanamycin, 91% to streptomycin and 64% to trimethoprim-sulphamethoxazole. All isolates
were sensitive to ceftriaxone, ciprofloxacin, gentamicin, nalidixic acid and norfloxacin. Drug
resistance to 3 or more drugs was shown by 45% of strains.
Table: Information about Libyan children with diarrhea and their Shigella isolates
Length of Faeces with Presence of Species and
Patient Sex Age Month of diarrhea Episode serotype of
(months) occurrence (days) per day Mucus Blood Fever Vomiting Shigella
1 F 11 Sep 1 5 + + − − S. sonnei
2 F 30 Sep 2 3 − − − − S. flexneri type 2
3 M 27 Oct 1 6 − − + − S. sonnei
4 F 18 Oct 1 8 − − − − S. flexneri type 2
5 F 36 Oct 2 5-7 + + + − S. flexneri type 2
6 M 7 Dec 7 7-8 − − + − S. flexneri type 1
7 M 7 Apr 1 10 + + + + S. flexneri type 2
8 M 13 Jun 10 6-7 + + + + S. flexneri type 3
9 M 32 Jul 1 4 + + + + S. sonnei
DISCUSSION:
In the present study Sh. flexneri was found to be the most frequent isolate in children with
Shigella-associated diarrhoea in Tripoli with type 2 being the predominating serotype. These
findings conform with studies in Algeria,7 Jordan,8 Kuwait,9 Saudi Arabia,10 and other
developing countries.11,12 In some countries, shigellae were isolated more often from children
greater than 2 years of age than from younger children.13,14 In our experience Shigella spp. were
isolated only from children who were not breast-fed and significantly more frequently from
children older than one year of age. Human milk has been shown to protect against severe
shigellosis in children up to 35 months of age.15,16 Studies showed that all milk samples obtained
from mothers contained antibodies to antigens encoded by the large virulence plasmid in strains
of Shigella.17 In addition to this, children more than one year old are capable of moving around
and becoming into more direct contact with other children and adults which expose them, under
certain circumstances, to infection with these organisms.
Food and waterborne outbreaks of shigellosis have been reported from different parts of
the world.18,19 Most (78%) of our patients with stools positive for Shigella used untreated
drinking water supplies. In a waterborne outbreak of shigellosis, occured in 1995, in a Libyan
family of 8 members, we isolated Sh. flexneri from 5 members and from the contaminated water
used for drinking by all members of this family (K.S. Ghenghesh, unpublished data).
We found blood and mucus in the stools of 56% and fever in 67% of our patients. These
clinical findings are in line with those reported by other investigators in under-developed
countries.11,12
Several investigators reported cases of generalized convulsions associated with
shigellosis.9,20,21 Of our patients, only one (11%) had generalized convulsions and we believe this
the first time such a case to be reported from Libya. Daoud et al.9 studied 93 children with
shigellosis and found 15% of the patients developed generalized convulsions. They reported that
neither specific diagnostic procedures nor drug therapy are usually necessary due to the benign
and self-limiting nature of convulsions associated with shigellosis.
Antibiotics can be beneficial in the treatment of Shigella-associated diarrhoea, however
trimethoprim-sulphamethoxazole should no longer be considered the drug of choice as the
majority (64%) of the local isolates were resistant to this antibiotic. Several studies from the
Middle East reported the same findings.9,10 al-Eissa et al.10 from Saudi Arabia reported 74% of
their Shigella isolates were resistant to trimethoprim-sulphamethoxazole. All our isolates were
sensitive to ceftriaxone, ciprofloxacin, nalidixic acid, norfloxacin and most of them to ampicillin
thus, should be considered the drugs of choice for treatment of diarrhoea due to shigellae.
However, susceptibility testing before administring antibiotics is recommended.
The present study shows that Shigella-associated diarrhoea in children is still a public
health problem in Libya and proper measures to combat it should be taken.
REFRENCES:
1. Rennels MB, Levine MM. Calssical bacterial diarrea: perspective and update - Salmonella,
Shigella, Escherichia coli, Aeromonas and Plesiomonas. J Pediatr Infect Dis 1986; 5 (Suppl):
S91-100.
2. Hossain MA, Albert MJ, Hasan KZ. Epidemiology of shigellosis in Teknaf, a coastal area of
Bangladesh: a 10 - year survey. Epidemiol Infect 1990; 105: 41-49.
3. Bennish ML, Harris JR, Wojtyniak BJ, Struelens M. Death in shigellosis: incidence and risk
factors in hospitalized patients. J Infect Dis 1990; 161: 500-506.. Huskins WC, Griffiths JK,
Faruque AS, Bennish ML. Shigellosis in neonates and young infants. J Pediatr 1994; 125: 14-22.
5. Collee JG, Duguid JP, Fraser AG, Marmion BP. Practical Medical Microbiology. Churchill
Livingstone, 1989.
6. Bauer AW, Kirby WMM, Sherris JC, Turk M. Antibiotic susceptibility testing by standardized
single disc method. Am J Clin Path 1966; 45: 493-496.
7. Shkarin VV, Ouchfoun A, Minaev VI, Naceur D. Epidemiology of bacillary dysentery in
Algeria. I. The epidemiological aspects of dysentery in Algeria (in Russian). Zhurnal
Mikrobiologii Epidemiologii i Immunobiologii 1983; 3: 49-53.
8. Rawashdeh MO, Ababneh AM, Shurman AA. Shigellosis in Jordanian children: a clinico -
epidemiologic prospective study and susceptibility to antibiotics. J Trop Pediatr 1994; 40: 355-
359.
9. Daoud AS, Zaki M, Al-Mutairi G, et al. Childhood shigellosis:clinical and bacteriological
study. J Trop Med Hyg 1990; 93: 275-279.
10. al-Eissa y, al-Zamil F, al-Kharashi M, Kambal A, Chowdhury M, al-Ayed I. The relative
importance of Shigella in the aetiology of gastroenteritis in Saudi Arabia. Scand J Infect Dis
1992; 24: 347-351.
11. Dutta P, Bhattacharya SK, Sen D, et al. Shigelosis in children: a prospective hospital based
study. Indian Pediatr 1992; 29: 1125-1130.
12. Thisyakorn US, Rienprayoon S. Shigellosis in Thai children: epidemiologic, clinical and
laboratory features. J Pediatr Infect Dis 1992; 11: 213-215.
13. Escheverria P, Sethabutr O, Pitarangsi C. Microbiology and diagnosis of infections with
Shigella and enteroinvasive Escherichia coli. Rev Infect Dis 1991; 13 (Suppl), S220-225.
14. Mertens TE, Wijenayake R, Pinto MR, et al. Microbiological agents associated with
childhood diarrhoea in the dry zone of Sri Lanka. Trop Med Parasitol 1990; 41: 115-120.
15. Ahmed F, Clements JD, Rao MR, et al. Community-based evaluation of the effect of
breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis in
Bangladeshi children. Pediatrics 1992; 90: 406-411.
16. Clemens JD, Stanton B, Stoll B, et al. Breast feeding as a determinant of severity in
shigellosis: evidence for protection throughout the first three years of life in Bangladeshi
children. Am J Epidemiol 1986; 123: 710-720.
17. Cleary TC, Winsor DK, Reich D, et al. Human milk immunoglobulin A antibodies to
Shigella virulence determinants. Infect Immun 1989; 57: 1675-1679.
18. Levine WC, Stephenson WT, Craun GF. Waterborne disease outbreaks, 1986-1988. MMWR
CDC Surveillance Summary 1990; 39: 1-13.
19. Samonis G, Elting L, Skoulika E, et al. An outbreak of diarrhoeal disease attributed to
Shigella sonnei. Epidemiol Infect 1994; 112: 235-245.
20. Carson FR, Susan JL. Convulsions associated with shigellosis in children. Am Family
Physician 1989; 39: 217-219.
21. Zvulunov A, Lerman M, Ashkenazi S, et al. The prognosis of convulsions during childhood
shigellosis. Europ J Paediatr 1990; 149: 293-294.
اﻻﺳﻬﺎل ﻧﺘﻴﺠﺔ اﻧﻮاع اﻟﺸﻴﺠﻼت ﻓﻲ اﻻﻃﻔﺎل ﻓﻲ ﻃﺮاﺑﻠﺲ -ﻟﻴﺒﻴﺎ
ﻣﻠﺨﺺ:
اﻷهﺪاف :ﺗﺤﺪﻳﺪ ﻣﺪى اﻧﺘﺸﺎر اﻧﻮاع اﻟﺸﻴﺠﻼت ﻓﻲ اﻻﻃﻔﺎل اﻟﻠﻴﺒﻴﻴﻦ اﻟﻤﺼﺎﺑﻴﻦ ﺑﺎﻻﺳﻬﺎل واﻻﻃﻔﺎل اﻻﺻﺤﺎء وﺣﺴﺎﺳﻴﺔ اﻧﻮاع
اﻟﺸﻴﺠﻼت اﻟﻤﻌﺰوﻟﺔ ﻟﻠﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ.
اﻟﻄﺮق :ﻓﻰ اﻟﻔﺘﺮة ﻣﺎﺑﻴﻦ ﺳﺒﺘﻤﺒﺮ 1992و اﻏﺴﻄﺲ 1993ﺗﻢ اﻟﻜﺸﻒ ﻋﻦ وﺟﻮد اﻧﻮاع اﻟﺸﻴﺠﻼت ﻓﻰ ﻋﻴﻨﺎت ﺑﺮاز ﻣﻦ 157ﻃﻔﻞ
ﻣﺼﺎب ﺑﺎﻻﺳﻬﺎل )ﺣﺎﻻت( و 157ﻃﻔﻞ ﺳﻠﻴﻢ ﻣﻦ ﻧﻔﺲ اﻟﻌﻤﺮ واﻟﺠﻨﺲ .ﻳﺘﺮواح ﻋﻤﺮ اﻻﻃﻔﺎل ﻣﺎﺑﻴﻦ ﻋﺪة اﻳﺎم وﺛﻼﺛﺔ ﺳﻨﻮات.
اﻟﻨﺘﺎﺋﺞ :ﺗﻢ ﻋﺰل اﻧﻮاع اﻟﺸﻴﺠﻼت ﻣﻦ (%5.7) 9اﻃﻔﺎل ﻣﺼﺎﺑﻴﻦ ﺑﺎﻻﺳﻬﺎل وﻣﻦ (%1.3) 2اﻃﻔﺎل اﺻﺤﺎء ﻣﻊ ﺳﻴﺎدة اﻟﻤﺼﻞ
ﺷﻴﺠﻼ ﻓﻠﻜﺴﻨﺮى ﻧﻮع . 2اﻏﻠﺐ ﺳﻼﻻت اﻟﺸﻴﺠﻼت ﺗﻢ ﻋﺰﻟﻬﺎ ﻓﻰ ﻓﺼﻞ اﻟﺨﺮﻳﻒ .اﻧﺘﺸﺎر اﻟﺸﻴﺠﻼت آﺎن اﻋﻠﻰ ﻣﻌﻨﻮﻳﺎ ﻓﻰ اﻻﻃﻔﺎل
اآﺒﺮ ﻣﻦ ﺳﻨﺔ وﻟﻢ ﻳﺘﻢ ﻋﺰﻟﻬﺎ ﻣﻦ اﻃﻔﺎل اﻗﻞ ﻣﻦ ﺳﺘﺔ اﺷﻬﺮ .آﻞ اﻟﺤﺎﻻت ) (%100ﺗﻨﺎوﻟﺖ ﺗﻐﺬﻳﺔ ﺻﻨﺎﻋﻴﺔ ،و %78اﺳﺘﺨﺪﻣﺖ ﻣﻴﺎﻩ
ﺷﺮب ﻏﻴﺮ ﻣﻌﺎﻟﺠﺔ .ﺗﻢ ﻣﺸﺎهﺪة دم وﻣﺨﺎط ﻓﻰ ﺑﺮاز %56ﻣﻦ اﻟﺤﺎﻻت .اﻟﻜﺸﻒ اﻟﻜﻠﻴﻨﻴﻜﻰ اﻇﻬﺮ %67ﻣﻦ اﻟﺤﺎﻻت ﻣﺼﺎﺑﺔ
ﺑﺎﻟﺤﻤﻰ و %33ﺑﺎﻟﻘﻰء .ﺣﺎﻟﺔ واﺣﺪة ﺗﻢ ﺗﺸﺨﻴﺼﻬﺎ ﻋﻠﻰ اﻧﻬﺎ ﺗﻌﺎﻧﻰ ﻣﻦ ﺗﻌﻔﻦ اﻟﺪم واﺧﺮى ﻟﺪﻳﻬﺎ اﻋﺮاض ﺗﺸﻨﺞ ﻋﺎم .آﻞ اﻟﺸﻴﺠﻼت
اﻟﻤﻌﺰوﻟﺔ آﺎﻧﺖ ﺣﺴﺎﺳﺔ ﻟﻠﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ ﺳﻔﺘﺮﻳﺎآﺴﻮن ،ﺳﻴﺒﺮوﻓﻠﻮآﺴﺎﺳﻴﻦ ،ﺟﻨﺘﺎﻣﻴﺴﻴﻦ ،ﻧﺎﻟﻴﺪﻳﻜﺴﻴﻚ اﺳﻴﺪ ،وﻧﻮرﻓﻠﻮآﺴﺎﺳﻴﻦ.
ﻣﻘﺎوﻣﺔ 3ﻣﻀﺎدات ﺣﻴﻮﻳﺔ او اآﺜﺮ آﺎن ﻓﻰ %45ﻣﻦ اﻟﺸﻴﺠﻼت.
اﻻﺳﺘﻨﺘﺎﺟﺎت :ﻧﻈﺮا ﻻن اﻏﻠﺐ اﻟﺸﻴﺠﻼت اﻟﻤﻌﺰوﻟﺔ آﺎﻧﺖ ﻣﻘﺎوﻣﺔ ﻟﻠﺘﺮاﻳﻤﺜﻮﺑﺮﻳﻢ-ﺳﻠﻔﺎﻣﻴﺜﻮآﺴﺎزول ) ،(%64ﻓﻬﺬا اﻟﻤﻀﺎد اﻟﺤﻴﻮي
ﻳﺠﺐ اﻻ ﻳﻌﺘﺒﺮ ﻣﻦ اﻻدوﻳﺔ اﻟﺘﻰ ﺗﺴﺘﺨﺪم ﻓﻰ ﻋﻼج اﻻﺳﻬﺎل اﻟﺬى ﺗﺴﺒﺒﻪ اﻟﺸﻴﺠﻼت ﻓﻰ ﻟﻴﺒﻴﺎ .هﺬﻩ اﻟﺪراﺳﺔ اوﺿﺤﺖ ان اﻻﺳﻬﺎل
اﻟﺬى ﺗﺴﺒﺒﻪ اﻟﺸﻴﺠﻼت ﻻﻳﺰال ﻣﺸﻜﻠﺔ ﺻﺤﻴﺔ ﻋﺎﻣﺔ ﻓﻲ ﻟﻴﺒﻴﺎ وان اﻻﺟﺮاءات اﻟﻤﻨﺎﺳﺒﺔ ﻟﻌﻼج هﺬﻩ اﻟﻤﺸﻜﻠﺔ ﻳﺠﺐ اﺧﺬهﺎ.